Abstract
Many informal caregivers of persons with dementia suffer adverse health consequences. Although established psychoeducation programs are known to benefit caregivers, attending in-person programs is challenging for them. To address this challenge, the Savvy Caregiver Program, an evidence-based psychoeducation program with demonstrated effectiveness for caregiving and disease-related outcomes, was transformed into an on-line program, Tele-Savvy. This article describes the rationale for and design of a prospective longitudinal randomized controlled trial (targeted N = 215), currently underway. The trial aims to establish Tele-Savvy's efficacy in (i) reducing the negative effects of caregiving on caregivers; (ii) promoting care recipients’ quality of life; (iii) improving caregiver mastery; and to explore (iv) Tele-Savvy's efficacy among caregivers of different races/ethnicities. The mediating role of mastery will be assessed. Participants are randomized to the active condition (immediate Tele-Savvy participation), attention control, or usual care. Participants in the two latter conditions will complete Tele-Savvy 6 months post-baseline. Multilevel mixed effects models will be used to examine changes in outcomes and to model group by time (months since baseline) interactions. The exploratory aim will be addressed using analysis of covariance and qualitative analysis. This trial's results may be used by healthcare and community organizations to implement Tele-Savvy in dementia care, increasing caregivers’ access to this evidence-based intervention.
Original language | English (US) |
---|---|
Pages (from-to) | 107-120 |
Number of pages | 14 |
Journal | Research in Nursing and Health |
Volume | 41 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2018 |
Funding
The authors are grateful to the following researchers for their permission to use instruments: Anthony Jorm, Margaret Sebern, Carol Whitlatch, Carol Farran, Louis Fogg, Judith McCann, Caryn Etkin, Xinqi Dong, Lisa Barnes, Catherine Cook-Cottone, and Wendy Guyker. This study is funded by the National Institute on Aging (NIA) of National Institutes of Health (NIH) under Award Number R01 AG054079. Additionally, the National Institute on Aging funded the following Alzheimer's Disease Centers that participated in protocol development: 2P50 AG025688, Emory University; P30 AG101061, Rush University; P30 AG13854, Northwestern University Feinberg School of Medicine; P30 AG008017, Oregon Health & Science University.
Keywords
- Alzheimer's disease
- caregivers
- dementia
- randomized controlled trials
ASJC Scopus subject areas
- General Nursing